SETD2 Antibody - N-terminal region

Produktübersicht

• Artikelname: SETD2 Antibody - N-terminal region
• Artikelnummer: ASB-ARP47617_T100
• Hersteller Artikelnummer: ARP47617_T100
• Alternativnummer: ASB-ARP47617_T100-25UL,ASB-ARP47617_T100-100UL
• Hersteller: Aviva
• Wirt: Rabbit
• Kategorie: Proteine/Peptide
• Applikation: IHC, WB
• Spezies Reaktivität: Canine, Equine, Human, Rat
• Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human SETD2
• Alternative Synonym: LLS, HYPB, SET2, HIF-1, HIP-1, KMT3A, HBP231, HSPC069, p231HBP

Produktbeschreibung

Huntingtons disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. SETD2 is a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs.

Produkteigenschaften

• Klonalität: Polyclonal
• Konzentration: 1.0 mg/ml
• Molekulargewicht: 97kDa
• NCBI: 29072
• UniProt: Q9BYW2
• Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.

Bilder

SETD2 antibody - N-terminal region (ARP47617_T100) validated by IHC using Human Placenta lysate at 4.0-8.0.

Human HepG2 cellsSETD2 is strongly supported by BioGPS gene expression data to be expressed in Human HepG2 cells

Host: Rabbit
Target: SETD2
Positive control (+): Hela (HL)
Negative control (-): MCF7 (N10)
Antibody concentration: 2.5ug/ml

SETD2 antibody - N-terminal region (ARP47617_T100) in Human HepG2 using Western Blot